Guggenheim analyst Jack Wallace lowered the firm’s price target on Accolade to $13 from $17 and keeps a Buy rating on the shares after considering the lower visibility offered by management’s updated multi-year growth plan. However, the firm e still thinks Accolade can approach 20% annual growth and generate 300-400 basis points of annual margin expansion with solid execution, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Accolade price target lowered to $10 from $12 at Wells Fargo
- Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
- Accolade price target lowered to $13 from $17 at Needham
- Accolade price target lowered to $16 from $18 at Canaccord
- Accolade price target lowered to $11 from $13 at Barclays